ICL670
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ICL670, covering 2011-01-20 to 2017-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions [Phase 2]